Refractory Epilepsy: Cannabinoid Challenges & Benefits
Experimental data suggesting benefits of cannabinoid comes from purified, standardized preparations that may not translate to real world practice.
Neuro News Roundup: Stroke Outcomes
Studies include stroke risk with epilepsy, genetic predisposition for ischemic stroke, and dysphagia screening in stroke patients.
Interesting Neuro: Tumor Tx and Stroke Recovery
March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.
Epilepsy, Syncope, or Both?
Common presentations between epilepsy and syncope complicate the differential diagnosis, making syncope the most frequent misdiagnosis in epilepsy.
Epilepsy Risk with Depression
Researchers evaluated several databases to determine whether or not depression has a causative role on epilepsy, or vice versa.
Top 10 Neurology Apps
Ten general and disease-specific apps for neurologists include assessment scales, anatomical diagrams, and interactive clinical decision support.
Interesting Neuro: Stroke Risks & Treatment
February news includes stroke risk with Alzheimer disease & migraine, neonatal hemorrhagic stroke, and head trauma in sports.
Incident Epilepsy Risk among the Elderly
Stroke is the most common cause of epilepsy in older adults, but there is limited information about rates and risk factors in this population.
Methylphenidate: Effect on Cognition in Epilepsy
Previous studies of methylphenidate in epilepsy patients have suffered from small numbers and methodological issues, such as lack of blinding.
Interesting Neuro: Epilepsy Outcomes & Vitamin D
January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.